Tag: Epidyolex

September 23, 2019 Off

GW paves way to launch Epidylex in Europe

By Dino Mustafić

GW Pharmaceuticals paved a way to launch Epidyolex in Europe, for use as adjunctive therapy of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients 2 years of age and older.